Molecular and cellular biology of rhabdomyosarcoma

Carla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, Pier Luigi Lollini, Patrizia Nanni

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.

Original languageEnglish
Pages (from-to)1449-1475
Number of pages27
JournalFuture Oncology
Volume5
Issue number9
DOIs
Publication statusPublished - 2009

Fingerprint

Rhabdomyosarcoma
Cell Biology
Molecular Biology
Muscle Development
Age of Onset
Sarcoma
Histology
Animal Models
Therapeutics

Keywords

  • Animal models
  • Gene-expression profiling
  • IGF
  • p53
  • PAX-FKHR
  • Rhabdomyosarcoma
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Molecular and cellular biology of rhabdomyosarcoma. / De Giovanni, Carla; Landuzzi, Lorena; Nicoletti, Giordano; Lollini, Pier Luigi; Nanni, Patrizia.

In: Future Oncology, Vol. 5, No. 9, 2009, p. 1449-1475.

Research output: Contribution to journalArticle

De Giovanni, Carla ; Landuzzi, Lorena ; Nicoletti, Giordano ; Lollini, Pier Luigi ; Nanni, Patrizia. / Molecular and cellular biology of rhabdomyosarcoma. In: Future Oncology. 2009 ; Vol. 5, No. 9. pp. 1449-1475.
@article{9cc65c122df84686b1787d7eed0c7ab0,
title = "Molecular and cellular biology of rhabdomyosarcoma",
abstract = "Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.",
keywords = "Animal models, Gene-expression profiling, IGF, p53, PAX-FKHR, Rhabdomyosarcoma, Targeted therapy",
author = "{De Giovanni}, Carla and Lorena Landuzzi and Giordano Nicoletti and Lollini, {Pier Luigi} and Patrizia Nanni",
year = "2009",
doi = "10.2217/fon.09.97",
language = "English",
volume = "5",
pages = "1449--1475",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Molecular and cellular biology of rhabdomyosarcoma

AU - De Giovanni, Carla

AU - Landuzzi, Lorena

AU - Nicoletti, Giordano

AU - Lollini, Pier Luigi

AU - Nanni, Patrizia

PY - 2009

Y1 - 2009

N2 - Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.

AB - Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.

KW - Animal models

KW - Gene-expression profiling

KW - IGF

KW - p53

KW - PAX-FKHR

KW - Rhabdomyosarcoma

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=74949131708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949131708&partnerID=8YFLogxK

U2 - 10.2217/fon.09.97

DO - 10.2217/fon.09.97

M3 - Article

C2 - 19903072

AN - SCOPUS:74949131708

VL - 5

SP - 1449

EP - 1475

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 9

ER -